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accumulation of distinct abnormal polypeptides. Many
observations suggest that these various types of inclu-
sions arise through common mechanisms and elicit sim-Introduction
ilar host responses. For example, all these inclusionsA continuous threat to cell function and viability is the
contain components of the ubiquitin-proteasome degra-accumulation in cells of proteins with highly abnormal
dative pathway and also molecular chaperones, whichconformations. Protein structures, once formed, are not
represent the two main systems that protect eukaryoticvery stable chemical entities, and at 378C, in the highly
cells against the buildup of unfolded polypeptides.reactive environment of the cell, spontaneous denatur-
Exposure of cells to increased temperatures (e.g., aation and chemical modifications of proteins (e.g.,
shift from 378C to 428C), oxygen radicals, heavy metals,through oxidation, isomerization, or glycation) must be
or certain antibiotics may seem to represent quite dif-occurring continuously. The rate of such damage to cell
ferent challenges for a cell, but, in fact, they share theproteins can increase markedly upon exposure of cells
capacity to cause severe damage to proteins. It is not sur-to harsh environmental conditions, such as increased
prising, therefore, that common mechanisms emergedtemperatures, oxygen free radicals, or heavy metals (es-
early in evolution that enable cells to better withstandpecially mercury). Polypeptides with highly abnormal
these diverse physical and chemical insults. Virtually allconformations may also result from mutations that pre-
cells respond to these potentially toxic conditions byvent normal folding or prevent the association of a poly-
induction of a set of highly conserved genes that encodepeptide with other subunits or stabilizing cofactors. Be-
heat shock proteins (Hsps). This set of proteins functionscause an accumulation of unfolded proteins can have
as the major cellular defense against the accumulationvery deleterious effects on cell function, all cells expend
of damaged or mutant proteins. Among the Hsps ina significant fraction of their basal energy production to
eukaryotic cells are many molecular chaperones, whichensure that proteins are accurately expressed, correctly
function to retard protein denaturation and aggregation,folded, and targeted to the correct compartment. If na-
several antioxidant enzymes, which reduce oxidativetive conformations are lost through mutation or postsyn-
damage to cell proteins, and components of the ubiqui-thetic damage, cells have elaborate mechanisms to pre-
tin-proteasome pathway (Seufert and Jentsch, 1990;vent the aggregation of the unfolded molecules, to refold
Sommer and Seufert, 1992; Watt and Piper, 1997), whichthem, and if not possible, to hydrolyze the abnormal
catalyze the selective degradation of abnormal polypep-polypeptides back to amino acids (Table 1). These pro-
tides in the nucleus and cytosol (Hershko and Ciecha-tective systems appear of particular medical interest
nover, 1998; Schwartz and Ciechanover, 1999).since an accumulation of unfolded polypeptides in the
nucleus or cytosol can disturb normal cellular functions
and trigger apoptosis. The purpose of this essay is to
Molecular Chaperones and the Repairreview recent discoveries concerning the mechanisms
of Damaged Proteinsthat protect cells against such an accumulation of ab-
One large group of heat shock proteins functions asnormal proteins and to discuss how these mechanisms
molecular chaperones, including members of the Hsp70,are likely to be important in the nervous system in pro-
Hsp90, Hsp104, Hsp40 (DnaJ), and small Hsp (Hsp27,tecting against the appearance and progression of vari-
a-crystallins) families, all of which bind selectively toous neurodegenerative diseases.
denatured or partially unfolded domains in polypeptidesIn a wide variety of systemic diseases, unfolded poly-
(Johnson and Craig, 1997; Samali and Orrenius, 1998;peptides accumulate in cells, largely as insoluble inclu-
Feder and Hofmann, 1999). Most of these chaperonessions, and appear to play a critical role in disease patho-
are major cell constituents under normal conditions,genesis. The list of hereditary diseases caused by
where they are essential to ensure the proper foldingmutations that prevent normal folding is large, ranging
and intracellular localization of newly synthesized poly-from cystic fibrosis and a-1 antitrypsin deficiency to
peptides (Table 3). As nascent polypeptides emergemany hemoglobinopathies and thallassemia, where the
from the ribosome, most associate with Hsp70 and thenexcess globin chains precipitate as inclusions that
with other chaperones (such as TCP-1), which promotemarkedly distort red blood cell shape (Amrani et al.,
proper folding, while preventing unwanted interactions
or aggregation (Frydman and Hartl, 1996). Nevertheless,‡ To whom correspondence should be addressed (e-mail: sherman@
alpha.bbri.org) [M. Y. S.], alfred_goldberg@hms.harvard.edu [A. L. G.]). a significant fraction of newly synthesized polypeptides
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have been reported in brains of Alzheimer’s diseaseTable 1. Abnormal Proteins Rapidly Degraded by the Ubiquitin-
Proteasome Pathway patients (Gabbita et al., 1999), while overexpression of
this enzyme helps protect cells from oxidative stress• Incomplete proteins
(Moskovitz et al., 1998). The relative importance of these• Misfolded proteins (from mutations and biosynthetic errors)
different protective mechanisms must depend on the• Denatured proteins
• Free subunits of multimeric complexes nature of the mutated protein or the specific environ-
• Proteins that fail to bind cofactors mental stress.
• Oxidant-damaged proteins
• Membrane or secretory proteins that fail to fold in the ER
• Misdirected proteins (in incorrect compartments) Cellular Machinery for Degrading
Abnormal Proteins
All cell proteins are continually being synthesized and de-
graded back to amino acids, although at widely differentnormally fail to achieve their correct conformations and
are rapidly digested (Schubert et al., 2000). Under condi- rates. Elaborate enzymatic mechanisms have evolved to
ensure that the degradation of cellular proteins is a highlytions that cause widespread damage to cell proteins
(e.g., heat shock), the cell’s need for these chaperones selective process that eliminates certain proteins rapidly
and does not lead to nonspecific destruction of otherincreases further, and their expression rises as part of
the heat shock response. cell constituents. To achieve this selectivity, the majority
of proteins to be degraded are first marked by covalentOf particular importance in such stressed cells is the
ability of the cochaperones, Hsp70 and Hsp40, to pre- linkage to the small polypeptide cofactor, ubiquitin (Fig-
ure 1). The linkage of a chain of four or more ubiquitinsvent the aggregation of heat-denatured proteins (Table
3). Other heat shock proteins (and in many species, to a lysine on the substrate marks it for rapid breakdown
by the very large proteolytic complex, the 26S protea-production of the sugar, trehalose) also helps prevent
aggregation of damaged polypeptides (Johnson and some (Coux et al., 1996; Hershko and Ciechanover,
1998). This structure catalyzes the degradation of mostCraig, 1997). Moreover, Hsp70 and Hsp40 can function
in an ATP-dependent process to catalyze the refolding cell proteins (Rock et al., 1994; Coux et al., 1996). The
primary exceptions are membrane and extracellularof denatured or partially denatured molecules into enzy-
matically active forms (Bukau and Horwich, 1998). Per- components, which after endocytosis are degraded
within the lysosome. The 26S proteasome consists ofhaps most interesting is the ability of certain combina-
tions of chaperones (in particular Hsp70, Hsp104, and two 19S regulatory complexes situated at either end
of the 20S core proteasome, a hollow, barrel-shapedHsp40) to disassemble intracellular protein aggregates
and to accelerate the refolding of the insoluble molecules structure, within which proteins are degraded. Sub-
strates first bind via their ubiquitin chains to the 19Sinto soluble, native species (Parsell et al., 1994; Patino et
al., 1996; Glover and Lindquist, 1998) (Table 3). regulatory complex (Figure 1). This structure contains a
ring of ATPase molecules, which unfold globular pro-Another group of heat shock proteins serves to pro-
tect cells against oxygen free radicals. For example, teins and translocate them into the 20S proteasome for
degradation (Benaroudj and Goldberg, 2000). Concomi-superoxide dismutase, heme oxygenase, and catalase
can all be induced as part of the heat shock response tantly, the regulatory complex releases the chain of ubi-
quitin molecules, which are then recycled for use in theand help protect against oxidative damage to cell pro-
teins, DNA, and lipids (Amrani et al., 1993; Massa et degradation of other proteins.
The ubiquitin requirement for degradation and the iso-al., 1996). Each of these enzymes, if overproduced in
transgenic animals or in cultured cells, can protect cells lation of proteolysis within a microcompartment of the
cell, to which substrate entry is highly restricted, all helpfrom ischemia-reperfusion injury (Chan, 1996). The
amino acid in proteins most susceptable to oxidative ensure that degradation occurs in a highly selective and
efficient manner. Proteolysis occurs within the centraldamage is methionine, and many tissues, especially
brain and retina, contain the enzyme, methionine sulfox- chamber of the 20S proteasome, which contains six
proteolytic sites, two of which preferentially cleave afteride reductase (Moskovitz et al., 1996; Kuschel et al.,
1999), which specifically repairs this type of damage to hydrophobic residues, two after basic ones, and two
after acidic residues (Coux et al., 1996; Kisselev et al.,proteins. Interestingly, reduced levels of this enzyme
Table 2. Neurodegenerative Diseases with Inclusion Bodies Associated with Ubiquitin and Proteasome
Disease Inclusion Major Constituent
Alzheimer’s Neurofibrillatory Tangles Tau
Parkinson’s Lewy Body a-synuclein, crystallins
Lewy Body Dementia Lewy Body a-synuclein
Amyotrophic Lateral
Sclerosis Skein, Bunina Bodies SOD, neurofilaments
Polyglutamine Extension Disorders:
Huntington’s Nuclear, Cytosolic huntingtin
Spinocerebellar Nuclear, Cytosolic ataxins, 1,2 &3
Ataxias 1,2 &3
Spinobulbar Muscular Nuclear, Cytosolic Androgen Receptor
Atrophy (Kennedy’s)
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ubiquitin gene, which encodes multiple ubiquitin mole-Table 3. Functions of Molecular Chaperones Probably
cules in a linear polymer (Watt and Piper, 1997; HershkoImportant for Protection against Neurodegenerative Diseases
and Ciechanover, 1998). Its expression and subsequent• Prevent aggregation of mutant and damaged proteins
cleavage represents a special mechanism that enables• Catalyze protein folding and multimer assembly
the cell to generate large amounts of ubiquitin quickly• Solubilize aggregated proteins in cells
• Promote ubiquitination and degradation of abnormal proteins when the overall rate of proteolysis rises. For example,
• Promote proper folding and glycosylation of membrane and induction of the polyubiquitin gene occurs as part of
secreted proteins the heat shock response and also whenever a muscle
• Suppress apoptotic program atrophies (Mitch and Goldberg, 1996). In fact, cells that
• Regulate their own expression in cytosol and ER
are unable to express the polyubiquitin gene are unable
to withstand various protein-damaging conditions (Fin-
ley et al., 1987).
1999a). Thus, the proteasome, unlike typical proteases, These two main protective strategies, the repair of
does not simply cut a protein into two pieces, but instead damaged proteins and their selective degradation, are
these six sites together degrade proteins all the way to complementary mechanisms to eliminate unfolded poly-
small peptides (Kisselev et al., 1999b), which are in turn peptides, which may perturb cell function and initiate
rapidly hydrolyzed to amino acids by cytosolic pepti- cell death programs (see below). However, refolding and
dases. degradation are not independent processes involving
The exquisite specificity of the degradative process distinct cellular components, but appear to be linked at
results from the properties of enzymes for ubiquitin con- several levels. The ATPases within the 26S proteasome,
jugation (Figure 1). In this process, the ubiquitin mole- in addition to promoting proteolysis, have chaperone-
cule is first activated by the enzyme, E1, which transfers like activities and can block protein aggregation and
the ubiquitin to one of the cell’s z15 ubiquitin-carrier even promote the refolding of denatured proteins (Braun
proteins (E2s), which then, together with an ubiquitin- et al., 1999; Strickland et al., 2000). In addition, the chap-
protein ligase (E3), transfers the activated ubiquitin mol- erones Hsp70 and Hsp40, not only are important in pre-
ecule to the protein substrate. The selectivity in this venting aggregation and in refolding, but are also essen-
pathway comes primarily from the E3. Mammalian cells tial for the ubiquitination and rapid degradation of many
typically contain hundreds of different E3s, which func- abnormal species (Lee et al., 1996; Sherman and Gold-
tion with a specific E2 in the ubiquitination of different berg, 1996; Bercovich et al., 1997; Ohba, 1997). Appar-
types of protein. Although much has been learned re- ently, the capacity of these chaperones to associate
cently about E3 function (Table 1), it is still unclear how selectively with unfolded polypeptides facilitates sub-
unfolded or damaged proteins are recognized and se- strate recognition by E3s and perhaps degradation by
lectively degraded. proteasomes. These dual roles of the chaperones ap-
Among the genes induced upon heat shock of cells pear highly advantageous to the organism in dealing
with damaged polypeptides. Since it must be impossibleare certain ubiquitin-carrier proteins (E2s) and the poly-
Figure 1. The Ubiquitin-Proteasome Pathway
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for the chaperones to refold many types of abnormal
proteins (e.g., certain mutant proteins or ones covalently
damaged by oxygen radicals), the ability of the chaper-
ones to also facilitate the destruction of these proteins
appears quite important (e.g., it should prevent the con-
tinuous consumption of ATP by the chaperones in futile
attempts to refold these molecules).
Induction of the Heat Shock Proteins
and Their Protective Effects
It is now well established that the common intracellular
signal for induction of the heat shock proteins at high
temperatures and in other stressful conditions is the
appearance of many unfolded polypeptides in the cyto-
sol or nucleus (Goff and Goldberg, 1985; Ananthan et
al., 1986). For example, the heat shock response can Figure 2. Induction of Protective and Apoptotic Programs by Abnor-
be induced at normal temperatures by treatments that mal Proteins
cause the production of large amounts of abnormal poly-
peptides, such as incorporation of amino acid analogs
(which prevent normal folding) or puromycin (which
group of molecular chaperones in the ER (often termed
leads to premature termination of nascent polypeptides)
Grps), many of which are homologous to the cytosolic
(Goff and Goldberg, 1985). In addition, direct microinjec-
Hsps (Chapman et al., 1998; Welihinda et al., 1999).
tion into cells of unfolded polypeptides or the expression
This adaptation further enhances the ER’s capacity to
of large amounts of such polypeptides, but not the corre-
generate properly folded membrane and secreted pro-
sponding native proteins, induces this response (Goff
teins. Defects in this ER quality control system have
and Goldberg, 1985; Ananthan et al., 1986). Similarly, a
been observed in cells that express the mutant Preseni-
very large induction of Hsps also occurs upon treatment
lin 1 (Katayama et al., 1999), which predisposes to Alz-
of normal cells with inhibitors of the proteasome (e.g.,
heimer’s disease (see below).
lactacystin or MG132), which prevent the breakdown of
In all organisms studied, the induction of Hsps has
abnormal proteins (Bush et al., 1997; Lee and Goldberg,
been shown to increase cell viability at high tempera-
1998; Meriin et al., 1998) and leads to their accumulation.
tures and various other harmful conditions (Figure 2).
This ability of unfolded proteins to stimulate the expres-
For example, exposure of mammalian cells to a modest
sion of heat shock genes represents an elegant protec-
increase in growth temperature (e.g., 428C), by triggering
tive mechanism. To monitor the intracellular levels of
the HS response, enables the cells to withstand temper-
such abnormal, potentially toxic molecules, eukaryotic
atures that would otherwise be lethal (e.g., 458C), as well
and prokaryotic cells also utilize the capacity of chaper-
as to withstand a variety of other toxic insults, such as
ones to bind selectively unfolded polypeptides. In un-
oxidative stress, heavy metals, or ischemia. The protec-
stressed cells, the expression of the HS genes is nor-
tion against more toxic conditions induced by mild in-
mally inhibited by the presence of molecular chaperones
sults (i.e., by a nonlethal buildup of unfolded proteins)
(Liberek et al., 1992; Baler et al., 1996; Voellmy, 1996).
is often termed acquired stress tolerance (Li, 1983; Bur-
Increased transcription of the heat shock genes is trig-
don, 1987; Kampinga, 1993; Gabai and Kabakov, 1994;
gered when the abnormal proteins accumulate and pref-
Rokutan et al., 1998). It seems quite likely that the grad-
erentially bind to Hsp 90 (Zou et al., 1998) and Hsp70
ual accumulation of unfolded proteins in various human
(Shi et al., 1998), thus preventing these chaperones from
diseases similarly induces the HS proteins and thus
inhibiting the expression of heat shock genes.
helps retard disease progression and the eventual loss
Cells also contain efficient mechanisms to prevent
of cell viability (see below). The degree to which the
accumulation of mutant or misfolded proteins in the
HS response may protect against cellular damage in
secretory pathway. For example, in cystic fibrosis, which
specific diseases has been studied only to a very limited
results from mutations in the chloride channel, CFTR, extent, even though it is potentially very important and
and in an inherited form of Alzheimer’s disease (AD) merits in depth analysis. This question is particularly
caused by mutations in presinilin I, the abnormal protein important since pharmacological induction of Hsps
molecules fail to fold correctly in the endoplasmic reticu- might be an effective approach to reduce cell injury and
lum (ER). Such abnormal molecules are transported from retard disease progression.
the ER back into the cytosol where they are rapidly
degraded by the ubiquitin-proteasome pathway (Steiner
et al., 1998; da Costa et al., 1999; Honda et al., 1999; Protein Inclusions and Aggresome Formation
Kopito, 1999; Xiong et al., 1999). If this degradative If the cell’s ability to degrade or refold abnormal poly-
mechanism is insufficient to prevent the accumulation peptides is exceeded, as occurs experimentally when
of the abnormal proteins in the ER, cells respond by a mutant protein is expressed from a high copy plasmid
activation of the “unfolded protein response.” This tran- or when the proteasome is inhibited, the denatured or
scriptional program is analogous to the heat shock re- partially unfolded molecules accumulate and tend to
aggregate (Dubois et al., 1991; Gragerov et al., 1991;sponse in the cytosol and increases production of a
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Cotner and Pious, 1995; Kampinga et al., 1995; Johnston teasomes in such structures reduces the total capacity
of the cells for protein turnover.et al., 1998; Wigley et al., 1999). Eventually, they form
In the neurodegenerative diseases associated withinclusions that are large enough to sediment upon cen-
polyglutamine repeats, such as Huntington’s diseasetrifugation at low speeds (e.g., 5,000 3 g) and can even
(HD) and the spino-cerebellar ataxias, as well as in Alz-be seen by light microscopy. Most dramatically, when
heimer’s disease, and the prion disorders, the inclusionsmany foreign proteins are expressed at high levels in E.
appear to involve protein-protein interaction that arecoli or when such cells incorporate amino acid analogs
especially stable due to extensive formation of b sheetinto proteins (Prouty et al., 1975; Gragerov et al., 1991;
structures, which are held together by multiple hydrogenRinas and Bailey, 1993), the resulting polypeptides ini-
bonds (Bates et al., 1998; Lathrop et al., 1998). In addi-tially form small aggregates, which then coalesce into
tion, in the polyglutamine disorders some aggregatedlarge, dense inclusions that eventually can occupy up
polypeptides may be covalently cross-linked by trans-to 30% of the cytosol. A similar process occurs in reticu-
glutaminase (Cooper et al., 1997; Igarashi et al., 1998;locytes upon exposure to amino acid analogs (Klemes
Kahlem et al., 1998). Despite the chemical stability, theseet al., 1981) to mercury (a potent denaturant) and in
structures once formed, are not necessarily permanentcertain hemoglobinopathies (Asakura et al., 1977; Che-
cellular components, and can disappear with time duerian and Nordberg, 1983; Shelton et al., 1986; Beris et
to refolding or degradation (see below). In fact, in experi-al., 1988; Fowler, 1993). In these various experimental
mental models, the proteins in the inclusions appear tomodels, the precise composition of the inclusions and
be in a dynamic state, continually turning over and beingthe forces holding them together are largely unknown,
replaced by other unfolded molecules. For example, insince the inclusions have not been isolated and rigor-
transgenic mice, induction of huntingtin with an ex-ously studied.
panded polyglutamine repeat leads to the formation ofIt had been initially assumed that these inclusions
inclusion bodies and neurodegeneration, but, if subse-result from the inherent tendency of denatured proteins
quently huntingtin expression is prevented, inclusionto associate with one other to form insoluble aggre-
bodies can disappear (Yamamoto et al., 2000). More-gates. However, recent findings indicate that inclusion
over, the behavioral symptoms associated with the dis-body formation in mammalian cells is a more complex
ease are reversed. Even when a large fraction of theprocess, in which cellular machinery appears to be ac-
cytosol of bacteria (Prouty et al., 1975) or reticulocytestively involved. Generally, inclusions in the cytoplasm
(Klemes et al., 1981) is occupied by such inclusions,are found at the microtubular organization center (MTOK
the cells can completely eliminate these inclusions byor centrosome) (Anton et al., 1999; Garcia-Mata et al.,
proteolysis, if the production of the denatured proteins1999; Vidair et al., 1999; Wigley et al., 1999; Fabunmi et
ceases. Similarly, in cells treated with a proteasomeal., 2000), while in the nucleus, these bodies tend to
inhibitor, short-lived forms of the influenza virus nucleo-be found in discrete structures that had been termed
protein accumulated in the aggresome but then were“promyelocytic leukemia oncogenic domains” (PODS)
lost rapidly from these structures after the inhibitor was(Anton et al., 1999). Several recent publications indicate
removed (Anton et al., 1999). Either the insoluble ubiqui-that the formation of these inclusions is a multistep pro-
tinated proteins are directly digested by proteasomescess, which involves transport of smaller aggregates
(e.g., those present in the inclusions), or they undergofrom the cell’s periphery toward MTOK along the micro-
chaperone-mediated solubilization followed by protea-tubuli (Johnston et al., 1998; Garcia-Mata et al., 1999).
some-dependent hydrolysis. In either case, the aggre-Hsps, ubiquitinated proteins, ubiquitin-conjugating en-
some may function as a storage compartment that pro-zymes, and 26S proteasomes associate with the inclu-
tects the cell by isolating temporarily the denatured,sion bodies (Anton et al., 1999; Garcia-Mata et al., 1999;
potentially damaging polypeptides, until they can beVidair et al., 1999; Wigley et al., 1999; Fabunmi et al.,
refolded or digested. In addition to being of major mech-
2000) and form a large structure, recently termed the
anistic interest, this reversibility offers hope for the treat-
aggresome (Johnston et al., 1998). Aggregates of mu-
ment of these progressive conditions, if the pathogenic
tated membrane proteins, such as the CFTR variants in imbalance between the generation of the abnormal pro-
cystic fibrosis and the presenilin-1 mutant associated teins and their elimination can be altered.
with Alzheimer’s disease (Johnston et al., 1998; Wigley Following inhibition of the proteasome, a large fraction
et al., 1999), as well as cytosolic abnormal proteins (Gar- of the cell’s chaperones and proteasomes are also found
cia-Mata et al., 1999), can all be found in aggresomes. in the aggresome (Fabunmi et al., 2000). Therefore, when
It is noteworthy that aggresome formation is acceler- the cell’s protective machinery is overwhelmed with ab-
ated when proteasome inhibitors are added to block the normal proteins, the stressed cells appear to localize
degradation of the abnormal polypeptides (Johnston et them, together with chaperones and degradative appa-
al., 1998; Garcia-Mata et al., 1999). Presumably, reduc- ratus, to a special compartment in which the potentially
ing proteolysis exposes a process that occurs, although toxic polypeptides can be resolubilized, refolded, or un-
more slowly, in patients during the progression of many dergo degradation. By contrast, in nonstressed cells,
neurodegenerative diseases. The finding of large num- where chaperones and the proteasome are dispersed
bers of proteasomes associated with these inclusions throughout the cytosol and the nucleus, degradation of
must mean either that these structures are sites special- the majority of proteins appears to take place outside
ized for proteolysis or alternatively that the aggregated the aggresome. This segregation of the unfolded mole-
polypeptide in the inclusions resist degradation and may cules within the aggresome probably also helps reduce
even trap proteasomes in nonfunctional degradative the threat to cell homeostasis by limiting the capacity
of these unfolded proteins to associate with other cellcomplexes. It is even possible that the trapping of pro-
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constituents (e.g., nascent polypeptides, cell mem- One of the great mysteries concerning these neurode-
generative diseases is their tendency to specifically af-branes, etc.), which potentially could disrupt various
cellular functions. fect only certain neuronal populations (e.g., basal gan-
glia in HD or motorneurones in ALS). In these susceptible
cell populations, the defenses against these specific
abnormal proteins must be different or defective. In fact,Proteasomal Hydrolysis
of Polyglutamine-Containing Proteins when the abnormal genes responsible for Huntington’s
(Saudou et al., 1998) or Parkinson’s (Masliah et al., 2000)It is unclear whether the presence within the inclusions
of a high concentration of ubiquitinated proteins and diseases are expressed in cultured neurons or in brain,
the neuropathology is evident in those cell types, af-proteasomes indicates that proteolysis is occurring at
high rates in such structures or that there has been an fected by the human disease. An alternative possibility,
for which there is some evidence in HD, is that theseunsuccessful attempt of the proteasomal apparatus to
efficiently eliminate the abnormal insoluble molecules. susceptible neurons are the sites of somatic mutations,
such that their DNA contains a huntingtin with excep-The b sheets formed by extended polyglutamine se-
quences are likely to represent a major challenge for tionally long polyglutamine sequences. In other words,
these neurons may be expressing an even more abnor-the proteasomal ATPases, which disassemble and
translocate substrates into the 20S particle. It is pres- mal gene products than the rest of the brain (Telenius
et al., 1994; Aronin et al., 1995).ently unknown how the proteasome digests a ubiquiti-
nated polypeptide containing an extended polygluta-
mine domain, but it must do successfully most of the Protein Damage Can Induce Apoptosis
time. For example, in HD patients, the abnormal form If a cell’s protective systems are unable to handle the
of huntingtin accumulates in inclusions only in specific buildup of abnormal polypeptides, and if the induction
regions of the brain, even though this gene is also ex- of Hsps is insufficient to prevent their continued accu-
pressed in other neurons and other cell types. In these mulation, a program for cell suicide (apoptosis) may be
cells, the mutant huntingtin must be continually de- initiated (Gabai et al., 1998). In other words, when the
graded without the formation of inclusions. Indeed, re- cell’s mechanisms for repair, segregation and digestion
cent data indicate that in nonneuronal cell culture hun- of the unfolded proteins are inadequate, this situation
tingtin with extended polyglutamines is degraded with is recognized as sufficiently threatening to the organism
a half-life of several hours, by a proteasomal mechanism to trigger programmed cell death (Figure 2). For exam-
(E. Schweitzer, personal communication). It seems un- ple, apoptosis occurs in response to a variety of highly
likely that the 20S proteasome’s six peptidase sites that stressful treatments that are damaging to cell proteins
are trypsin-like, chymotrypsin-like, or caspase-like in (e.g., shifting cells rapidly from 378C to 458C). Cell death
their substrate specificities can actually cleave within a occurs apparently before the cells have sufficient time
polyglutamine stretch. Therefore, when the proteasome to induce the Hsps to achieve enhanced protection
digests a protein containing a normal or extended poly- (Mosser and Martin, 1992; Gabai et al., 1997; Mosser
glutamine tract, it probably releases long polyglutamine et al., 1997). Similarly, apoptosis can be triggered by
sequences, and the cytosolic peptidases that complete incubation with amino acid analogs or low doses of
the hydrolysis of proteasome products must be able puromycin (Sugita et al., 1995), which causes production
to digest peptides containing only glutamine residues. of improperly folded or incomplete proteins. Interest-
Otherwise, these relatively insoluble polyglutamine se- ingly, if shorter fragments of proteins are generated,
quences would aggregate and form inclusion bodies. they appear less toxic than longer ones, perhaps be-
In principle, each of these steps in the degradative cause they are more readily degraded or less likely to
pathway could on occasion fail, leading to the accumula- associate with other cell components (Chow et al.,
tion of the abnormal polypeptides. There is evidence 1995).
that the mutant form of ataxin-1 with an extended poly- A buildup of abnormal polypeptides in cells thus can
glutamine sequence is degraded by proteasomes ineffi- activate two opposing processes: (1) when there is a
ciently, despite normal rates of ubiquitination (Cum- large, rapid, and overwhelming accumulation of un-
mings et al., 1999). Perhaps the extended polyglutamine folded proteins, a rapid apoptosis occurs or (2) if lower
sequence interferes with complete degradation by the amounts of abnormal proteins are generated, then an
26S proteasome by causing tight associations with other induction of the Hsps occurs leading to an enhanced
molecules, and preventing protein entry into the 20S cellular capacity to handle the offending molecules.
particle. In such a case, the proteasome may release Whether the cells die or survive appears to depend on
a polyglutamine-containing fragment, which could be the net balance between these two programmed re-
more toxic than huntingtin itself. In cultured cell models, sponses, one of which protects the stressed cell, and
caspase-3 was shown to serve such a pathogenic role the other sacrifices it, presumably for the good of the
by cleaving the extended forms of huntingtin, ataxin, organism. For example, if mammalian cells are shifted
and the androgen receptor to smaller fragments that in a single step from 378C to 458C, most cells die by
contain the deleterious polyglutamine domains (Welling- apoptosis, but if there is a gradual increase in tempera-
ton et al., 1997; Martindale et al., 1998; Wellington et al., ture from 378C to 458C, a higher fraction of cells survive
1998; Ellerby et al., 1999). However, it remains uncertain due to their induction of Hsps (Gabai et al., 1998). These
what step actually fails in the affected neurons of pa- responses are not independent, since certain Hsps, in
tients leading to accumulation of these abnormal addition to inhibiting the transcription of heat shock
genes, play a critical role in preventing the activation ofspecies.
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the apoptotic program (Gabai et al., 1998) (see below) less of the chaperone is available to activate the phos-
phatase and, as a consequence, the activity of JNK(Figure 2).
increases. In this model for regulation of apoptosis, the
chaperones function to monitor the level of abnormalMechanisms for the Induction of Apoptosis
proteins in the cell, just as Hsp70 and Hsp90 monitorby Damaged Proteins
the levels of unfolded proteins and regulate the tran-Recently, important insights have been obtained as to
scription of HS genes in bacterial and eukaryotic cellshow abnormal proteins can trigger apoptosis. When
(Morimoto et al., 1996; Zou et al., 1998), and the ERmammalian cells are subjected to a variety of stressful
chaperone, BiP, monitors levels of unfolded proteinsconditions, a number of protein kinases are activated.
in the secretory pathway (Welihinda et al., 1999) andOne of these stress-activated kinases, called JNK, plays
controls the production of ER stress proteins. JNK isa key role in the activation of apoptosis triggered by
probably not the only target on which Hsp70 acts tounfolded proteins (for review, see Gabai et al., 1998)
inhibit the apoptotic program. Hsp70 can also inhibit(Figure 2). Inhibition of the JNK signaling pathway re-
assembly of the multiprotein complex (termed the apo-duces the ability of protein-damaging conditions, such
ptosome) that contains caspase 9 and triggers apo-as high temperatures, to induce programmed cell death.
ptosis (Beere et al., 2000; Saleh et al., 2000). However,JNK activates apoptosis by multiple mechanisms. It
since JNK promotes the release of cytochrome C fromphosphorylates the important proapoptotic protein,
mitochondria, which precedes apoptosome formationp53, which reduces p53 degradation (Fuchs et al., 1998),
(Tournier et al., 2000), the ability of Hsp70 to suppresssince the phosphorylated form is less susceptible to the
JNK activation may be the most important mechanismubiquitination. The resulting accumulation of p53 can
by which this chaperone reduces the capacity of abnor-trigger apoptosis. JNK also has a p53-independent
mal polypeptides to cause neuronal apoptosis.mechanism for activating apoptosis, which involves the
induction of the FAS ligand (Faris et al., 1998a, 1998b).
In addition, JNK increases the phosphorylation of the Consequences of the Accumulation of Proteins
with Extended Polyglutamine Domainsmajor antiapoptotic proteins Bcl-2 and Bcl-x, thus re-
ducing their antiapoptotic activity (Srivastava et al., Despite these various protective mechanisms, which
appear to function in neurons as in other cell types, the1999; Kharbanda et al., 2000). The two major isoforms,
JNK1 and JNK2, play an essential role in apoptosis in- accumulation of abnormal proteins in selective regions
of the brain correlates with the development of severalduced by DNA damage (Tournier et al., 2000) and in
neuronal apoptosis during brain development (Kuan et major neurodegenerative diseases. Among the most
thoroughly studied examples are the inherited condi-al., 1999). Interestingly, in the brain, there is a specific
JNK isoform, JNK3, which is essential for the neuronal tions that result from expansions of a polyglutamine
sequence, including Huntington’s Disease, which re-apoptosis induced by excitotoxic agents (e.g., kainic
acid), and perhaps other stimuli (Yang et al., 1997). It sults from alterations in huntingtin (Bao et al., 1996;
Gusella and Macdonald, 1998), the spinocerebellar atax-remains unclear which of these JNK isoforms is critical
in cell death caused by the accumulation of mutant ias (e.g., SCA1 and SCA3, which are caused by expan-
sions in ataxins 1 and 3), or spinal and bulbar musclepolypeptides in neuronal cells.
The accumulation of damaged proteins in cells stimu- atrophy (caused by an expansion of the polyglutamine
region in the androgen receptor) (Young, 1998; Cum-lates JNK in a novel way. Other toxic treatments (e.g.,
UV irradiation or osmotic shock) activate this kinase by mings et al., 1999). These diseases are not due to the
loss of the specific functions of these proteins but ratherincreasing its phosphorylation by upstream kinases. By
contrast, protein-damaging conditions (e.g., heat shock to the abnormal structures of these mutated molecules
(i.e., they result from toxic gain-of-function mutation). Inor oxygen radicals) stimulate JNK activity through an
inhibition of its dephosphorylation (Meriin et al., 1999). unaffected individuals, these proteins normally contain
long stretches (15–30) of glutamine residues, whoseThis step also is the site where Hsps act to reduce
apoptosis. Treatments that cause an induction of the conformations and specific functions are unknown. Ap-
parently, these polypeptides can be properly folded andheat shock response can prevent the activation of JNK
by protein-damaging insults and thus can lead to a sup- can be degraded without difficulty. However, when
these polyglutamine stretches become extended duepression of apoptosis (Gabai et al., 1997; Volloch et al.,
1998; Meriin et al., 1999; Yaglom et al., 1999). Critical in to expansion of CAG repeats, a variety of late onset
neurodegenerative diseases occurs.this regulation of JNK are the major heat shock protein
Hsp70 and, presumably, also its cofactor, Hsp40 (Hdjl). The best characterized and most common such dis-
ease is Huntington’s Disease (HD) (Young, 1998), whichSpecific inhibition of Hsp70 induction with antisense
RNA enhances JNK activation by protein-damaging in- results from an expansion of the polyglutamine stretch
in huntingtin, leading to its aggregation and abnormalsults (Gabai et al., 2000), while increased expression
of Hsp70 dramatically reduces the capacity of protein association with various cell proteins (Bates et al., 1998).
Eventually impaired neuronal function becomes evidentdamage to activate JNK (Gabai et al., 1997) (Figure 3).
An attractive model to explain the induction of apo- and may trigger cell death (Young, 1998). In HD patients,
there is extensive neuronal loss in the striatum and cere-ptosis by abnormal proteins and the influence of Hsp70
is that in unstressed cells Hsp70 binds to an unidentified bral cortex leading to a marked reduction in brain size
at later stages of the disease. In transgenic mice thatJNK phosphatase and maintains it in an active form. As
unfolded polypeptides accumulate in the stressed cells, express a fragment of huntingtin containing the ex-
panded polyglutamine, there are behavioral abnormali-they tend to preferentially bind to Hsp70. As a result,
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Figure 3. Possible Interrelation between Sol-
uble Abnormal Proteins and Large Inclusions
This model summarizes the different possible
fates of a mutant or damaged protein in neu-
rons and the factors that can influence these
alternative paths. Once synthesized, the ab-
normal protein may be partially or completely
unfolded and tend to form microaggregates
with itself and with other cell constituents.
Eventually, these structures can be trans-
ported into microscopically visible inclusions
(resembling “aggresomes”). Opposing these
developments are the molecular chaperones,
which, functioning in teams, may refold or
solubilize the abnormal polypeptides, and the
ubiquitin-proteasome pathway, which may
degrade them. On the other hand, ubiquitin-conjugation or cleavage by caspases may also reduce the protein’s solubility, thus favoring
formation of large inclusion bodies. There is also clear evidence that even after inclusion formation, the mutant polypeptides within these
bodies can be degraded or solubilized. In addition, the soluble abnormal proteins may disturb neuronal function by interacting with other cell
components or can activate stress-kinase JNK and trigger apoptosis by soaking up chaperones (especially Hsp70). It remains unclear whether
the insoluble inclusions also contribute to the neurodegeneration or if, by sequestering the potentially damaging polypeptides, their formation
may help reduce the cytotoxic effects. This summary also emphasizes how the apparent failure of abnormal proteins in aged organisms to
activate the heat shock response may reduce these protective mechanisms that help defend against these deleterious consequences.
ties similar to those in HD, but massive neuronal death 1998b). In instances, where cell death has been docu-
mented, the formation of intranuclear inclusions gener-was not found (Davies et al., 1997). Neurons that express
the mutant huntingtin differ from ones expressing the ally precedes it. Such observations initially led to the
widely held assumption that aggregate formation is thenormal forms in several respects, including a reduced
number of dendrites, reduced transport of dyes along critical event triggering neuropathology in HD and re-
lated diseases, although there is appreciable evidencethe neuron, and altered expression of receptors for exci-
totoxic transmitters (Young, 1998). At present, it is not against this view (see below).
Many features of the inclusions formed by the polyglu-clear which of these alterations (if any) causes the neuro-
logical symptoms, cellular loss, and eventually disease tamine-containing proteins are strikingly similar to those
of aggresomes. When expressed in cultured cells, theprogression. Interestingly, in C. elegans transfected with
the mutant huntingtin, the expressing neurons do not polyglutamine-containing proteins, like aggresomes,
form several inclusion bodies in the nucleus or one perundergo apoptosis, but show symptoms of neurodegen-
eration that could be suppressed by inhibitors of cas- cell in the cytosol. Recent results from several groups
indicate that huntingtin fragments with an expandedpases, the key proteolytic enzymes in the apoptotic
pathway (Faber et al., 1999). Thus, activation of certain polyglutamine tract form inclusions at the centrosome
in the cytosol (A. Meriin and M. S., unpublished data; T.components of the cell death program seems to play
a role in the neurodegeneration, even without causing Paul and K. Fishbeck, personal communication), while
ataxin-1-containing inclusions colocalize with PODs inclassic apoptosis. In fact, several observations on trans-
fected cells in culture suggest that the truncated forms the nucleus (Chai et al., 1999b). However, it remains
unclear whether formation of these inclusions requiresof huntingtin and ataxins that are found in inclusions
may be generated by caspase-mediated cleavages (El- the microtubule-dependent transport of small polyglu-
tamine aggregates into these large structures visiblelerby et al., 1999; Kobayashi et al., 1998; Martindale et
al., 1998; Wellington et al., 1998). The inclusions them- microscopically.
Several recent observations have further indicatedselves may also bind and further activate a caspase,
thus perhaps inducing programmed cell death or pro- that the formation of inclusion bodies by proteins in
these diseases is a highly regulated process. Treatmentmoting neurodegeneration (Miyashita et al., 1999; Ona
et al., 1999; Sanchez et al., 1999; Wang et al., 1999). of cells with glucocorticoids was found to strongly sup-
press the aggregation and nuclear localization of bothThe most obvious cellular manifestation of the poly-
glutamine diseases is the presence of the large protein androgen receptor and huntingtin fragments containing
expanded polyglutamine sequences (Diamond et al.,aggregates in the affected neurons either within the nu-
cleus or the perinuclear zone (Davies et al., 1997; Difiglia 2000). This steroid appears to be acting through its re-
ceptor to cause the transcription of a still unidentifiedet al., 1997; Cooper et al., 1998; Martindale et al., 1998).
An important factor promoting aggregation of huntingtin factor that inhibits the aggregation of these mutant pro-
teins. In addition, components of cellular signaling path-in vivo is its proteolytic cleavage to smaller fragments
containing the polyglutamine stretch (Goldberg et al., ways were also found to promote the formation of inclu-
sion bodies. When the protein kinase MEKK1, which1996; Difiglia et al., 1997; Kahlem et al., 1998; Wellington
et al., 1998). Because these polyglutamine-rich frag- catalyzes an early step in JNK signaling pathway, is
activated, it stimulates the formation of the inclusionments contain less of the globular domains, they would
be expected to be more prone to aggregate, to form b bodies (A. Meriin and M. S., unpublished data). These
observations further indicate that the inclusion bodysheets (Perutz, 1999) and perhaps to undergo cross-
linking by transglutaminase (Kahlem et al., 1996, 1998a, formation represents a complex cellular response,
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which presumably evolved as a protective mechanism. promotes apoptosis through its ability to block the deg-
radation of other regulatory proteins.Further understanding of this process could even have
therapeutic implications. Several other observations also argue strongly that
the soluble polyglutamine-containing molecules, ratherAnother feature of inclusions containing ataxin-1 (Chai
et al., 1999a), ataxin-3 (Cummings et al., 1998), and hun- than those in inclusion bodies, are in fact the critical
species triggering apoptosis. Deletion of the C-terminaltingtin (Wyttenbach et al., 2000) that they share with
aggresomes is their association with the molecular portion of huntingtin enhances formation of inclusions
but does not increase the fraction of apoptotic cellschaperones Hsc73, the member of the Hsp70 family
found in normal cells, and its cofactor Hdj, a member (Saudou et al., 1998). Furthermore, deletion of the self-
association regions of ataxin-1 blocks aggregation butof the Hsp40 (DnaJ) family. Finally, like many abnormal
proteins in aggresomes, huntingtin and ataxin1 in the does not suppress apoptosis (Klement et al., 1998).
Moreover, in transgenic mice lacking the ubiquitin-pro-inclusion bodies appear to be ubiquitinated (Kalchman
et al., 1996; Cummings et al., 1998) and are associated tein ligase, E6-AP, formation of ataxin-1 inclusion bodies
is reduced, while toxicity is more prominent (Cummingswith proteasomes (Cummings et al., 1998; Chai et al.,
1999a, 1999b). Presumably, the abnormal molecules ac- et al., 1999b). These observations suggest that a soluble
form of these abnormal molecules is the primary triggercumulate and form inclusions due to the cell’s failure to
rapidly degrade these polypeptides. Accordingly, treat- of apoptosis in these cells (Figure 3). Inclusion formation
may even be protective by reducing the concentrationment of the cells with proteasome inhibitors resulted
in greater accumulation of polyglutamine polypeptides, of the unfolded molecules in the soluble phase. This
conclusion would be consistent with the hypothesis thatincrease in number of inclusion bodies, and enhanced
apoptosis (Chai et al., 1999b; Cummings et al., 1999a, the inclusions are a form of aggresome, which consti-
tutes a cellular defense mechanism to segregate and1999b). Interestingly, transfection of neurons with a
dominant-negative mutant of the ubiquitin-conjugating limit the toxic consequences of the abnormal proteins.
While many aspects of neuronal function are clearlyenzyme, Cdc34, also reduced the number of inclusion
bodies formed by huntingtin (Saudou et al., 1998). Al- altered in these neurodegenerative diseases (e.g., the
number of dendrites, transport of molecules along thethough these data suggest that ubiquitination of hun-
tingtin is critical for the formation of inclusions, there is neuron, expression of receptors for excitotoxic transmit-
ters), it is quite unclear whether the inclusions or solubleno evidence that the effect of Cdc34 is due to direct
ubiquitination of the huntingtin and not of some other species may cause such changes, since only the rela-
tionship to apoptosis has been studied (Figure 3).essential protein.
The extended forms of the polyglutamine-contain-
ing proteins also exhibit another property characteristic Neuronal Protection by Molecular Chaperones
of unfolded polypeptides: they can cause the induction Based on the findings on other cells expressing various
of Hsps. For example, the expression of ataxin-1 or abnormal proteins, it seems very likely that Hsps, espe-
ataxin-3 with expanded polyglutamines in HeLa cells cially Hsp70 and its cofactor Hsp40 (Hdj1), also serve
leads to an induction of Hsp70 (Cummings et al., 1998; important protective roles in neurons that express mu-
Chai et al., 1999a). Similar effects of polyglutamine-con- tant proteins with polyglutamine expansions. In Dro-
taining polypeptides on induction of Hsps were ob- sophila models of human polyglutamine diseases, over-
served in C. elegans expressing huntingtin (Satyal et al., production of Hsp70 and Hsp40 strongly protected
2000). Thus, these extended forms do activate signaling neurons that expressed mutant forms of human hunting-
pathways and can induce apoptosis in similar ways as tin (Warrick et al., 1999; Fernandez-Funez et al., 2000;
other types of unfolded polypeptides. In fact, it has re- Kazemi-Esfarjani and Benzer, 2000). In neuronal cul-
cently been reported that cell death induced by hunting- tures, expression of Hsp70 and Hsp40 protected cells
tin is dependent on the activation of JNK (Liu, 1998; from apoptosis induced by the mutant androgen recep-
Yasuda et al., 1999), and therefore must be regulated tor (Kobayashi et al., 2000). Similarly, overproduction of
by the level of Hsp70 and related chaperones. However, another chaperone Hsp104 in C. elegans dramatically
other apoptotic pathways, perhaps independent of JNK, reduced neurotoxicity of the mutant huntingtin (Satyal
may also be involved in HD. For example, there is evi- et al., 2000).
dence that caspase 8 can be activated by association There are several possible mechanisms by which
with inclusion bodies, and this activation may also con- these chaperones might help protect the neurons. (1)
tribute to huntingtin-induced dysfunction and apoptosis The Hsps may help combat the tendencies of huntingtin
(Sanchez et al., 1999). and ataxin to unfold and aggregate. In fact, in yeast
Although apoptosis is often associated with the for- cells, these chaperones can reduce the formation of
mation of inclusions in cells expressing proteins with inclusion bodies by a huntingtin fragment with expanded
extended polyglutamines, these aggregates may not be polyglutamine and in vitro decrease aggregation of this
the cause of cell death. For example, when the domi- fragment (Muchowski et al., 2000). The huntingtin frag-
nant-negative form of the ubiquitin-conjugating enzyme, ment tends to form two types of aggregates, either amy-
Cdc34 was transfected into such cells, it suppressed loid-like fibrils that are unusual in resisting solubilization
the formation of inclusions, but actually led to increased by the ionic detergent SDS, or amorphous structures
apoptosis. This intriguing result may be because the that can be solubilized with detergents. Hsp70 and its
dominant-negative Cdc34 blocked degradation of the cofactor Hsp40 can bind to the soluble molecules and
huntingtin and, as a result, greater accumulation of this facilitate the formation of the amorphous aggregates,
while suppressing formation of the fibrillar structuresprotein, but it is also possible that this inhibitory E2
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(Muchowski et al., 2000). It remains to be determined neuronal apoptosis (Figure 3). For example, in the sub-
stantia nigra of patients with Parkinson’s disease,whether chaperones have similar effects in neurons. (2)
a-synuclein, a very abundant presynaptic protein of un-The abnormal species, whether soluble or aggregated,
known function, accumulates in inclusions, termed Lewyprobably serve as seeds to which other partially un-
Bodies, in cell bodies and neurites (Mezey et al., 1998)folded proteins associate and, thus, may inhibit the suc-
of dopaminergic neurons. a-synuclein was first impli-cessful folding of newly synthesized polypeptides. By
cated in the pathogenesis of Parkinson’s Diseasebinding to the abnormal species, the Hsps may reduce
through the identification of mutated forms of this pro-this interference with folding. (3) In addition to associat-
tein in families having the inherited forms of this diseaseing with aggregated species and perhaps promoting
(Polymeropoulos et al., 1997). However, in importanttheir resolubilization, the chaperones may bind prefer-
recent studies, Lewy Bodies, the characteristic inclu-entially to the soluble polyglutamine-extended mole-
sions in noninherited forms of these and other neurode-cules and reduce their toxicity by preventing them from
generative diseases (e.g., multiple systems atrophy) haveinteracting with proteins that trigger apoptosis and neu-
been shown to contain an abnormal form of a-synuclein,rodegeneration. (4) The Hsps may also facilitate the ubi-
which contains nitrated tyrosine residues (Giasson etquitination and degradation of huntingtin and ataxins, as
al., 2000). This covalent modification results from oxi-Hsp70 and Hsp40 do for certain other abnormal proteins
dative damage to the protein and there had been ap-(Lee et al., 1996; Sherman and Goldberg, 1996; Bercov-
preciable evidence implicating oxidative injury in theich et al., 1997). Other chaperones may also contribute
pathogenesis of these diseases (Giasson et al., 2000).to these effects, for example, we have found in yeast
Oxygen free radicals (especially superoxide) by react-that a distinct chaperone, Hsp104 (but not Hsp70 or
ing with nitric oxide generate the highly reactiveHsp40), is essential for the degradation of ataxin-1 (D. H.
species, peroxynitrite, which modifies tyrosines in pro-Lee et al., submitted). (5) Finally, Hsp70, by inhibiting
teins, and presumably the resulting abnormal forms ofthe activation of JNK, should directly inhibit the ability
a-synuclein are particularly prone to aggregate in cells.of these mutant polypeptides to cause apoptosis. It
Similar inclusions containing ubiquitin and a-synucleintherefore appears likely that at some stages of the dis-
are also seen in patients with Dementia with Lewy bodiesease, the heat shock response is activated as part of
(DLB) (Baba et al., 1998; Spillantini et al., 1998; Takedathe standard cellular response to a buildup of abnormal
et al., 1998).proteins. However, reliable information on the levels of
Like the inclusions containing huntingtin and the atax-Hsp expression in neurons during progression of these
ins, the a-synuclein inclusions contain large amounts ofdiseases is unfortunately not available (see below). This
ubiquitin and proteasomes, presumably because thequestion is of appreciable importance since, in principle,
synuclein is ubiquitinated (Ii et al., 1997; Bennett et al.,treatments that cause induction of Hsps could be a very
1999). It is also possible that ubiquitination occurs afteruseful approach for therapy of these neurodegenerative
aggregation or that some of the ubiquitinated speciesdiseases.
are not a-synuclein. In all these conditions, the criticalIn certain experimental models of these diseases,
question remains, whether ubiquitinated polypeptidesspecific chaperones, though they may have evolved to
within the inclusions are being degraded, or whethermaintain proteins soluble, can surprisingly also favor
this degradation by the proteasomes is prevented forthe formation of inclusion bodies. In yeast models of
some reason, leading to the accumulation of these pro-prion disease (Lindquist, 1996; Tuite and Lindquist,
teins in association with proteasomes in inclusion1996; Newnam et al., 1999) and yeast expressing poly-
bodies.glutamine-extended huntingtin (Krobitsch and Lind-
One hereditary form of Parkinson’s Disease resultsquist, 2000), overexpression of Hsp104 can enhance
from mutations in the protein parkin (Kitada et al., 1998;the appearance of inclusions, while deletion of Hsp104
Tanaka et al., 1998), which has recently shown to be a
prevents this aggregation. This chaperone in yeast and
ubiquitin-protein ligase (E3), and in the patients, this
its homolog in bacteria, ClpB, have been shown to func-
enzymatic activity is lost. It remains to be determined
tion with Hsp70 and Hsp40 in solubilizing intracellular whether the substrate for parkin is a-synuclein. Other
aggregates of heat-damaged proteins (Glover and Lind- hereditary forms of Parkinson’s Disease are also associ-
quist, 1998; Diamant et al., 2000). On the other hand, ated with mutations affecting the ubiquitination system.
in yeast Hsp104 normally promotes the degradation of In one form, the mutation inactivates the ubiquitin car-
ataxin-1 by the proteasome (D. H. Lee et al., submitted). boxy-terminal hydrolase L1 (Leroy et al., 1998), one of
Possibly, overexpression of Hsp104 alone without its the cell’s many enzymes capable of removing ubiquitin
cofactors may be deleterious and actually interfere with from peptide conjugates. For unknown reasons, this
the protective effects of other Hsps. While other Hsps deubiquitinating enzyme is one of the most abundant
tend to be remarkably conserved from archaea to man, proteins in brain, and it is rapidly induced in Aplysia
Hsp104 has not been found in the cytosol or nucleus of during postsynaptic facilitation (Hegde et al., 1997). Cu-
mammalian or insect cells, perhaps because its activi- riously, mutations in a distinct deubiquitinating enzyme
ties in long-lived homeothermic cells can sometimes be are associated with a distinct neurodegenerative dis-
harmful. ease, gracile axonal dystrophy (Saigoh et al., 1999).
However, the precise role of these deubiquitinating en-
Abnormal Protein Inclusions in Parkinson’s Disease zymes in overall ubiquitin metabolism and in protein
In addition to the polyglutamine diseases, several other degradation is uncertain. Most likely, such mutations
major neurodegenerative diseases are also associated lead to a general disorder in ubiquitin recycling, but it’s
quite unclear why such a defect in Parkinson’s Diseasewith an accumulation of proteinaceous inclusions and
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would lead to a specific accumulation of a-synuclein tion, although the real significance of this ubiquitin spe-
cies awaits critical analysis.and not other abnormal brain proteins. In any case, it
is conceivable that the a-synuclein mutation, free radical Because of these striking similarities, it is attractive
to hypothesize that these diverse diseases all developdamage to this protein, or a failure to ubiquitinate
a-synuclein leads to an accumulation of abnormal spe- through a common mechanism in which the accumula-
tion of abnormal proteins in the affected neurons iscies, which interfere with normal cell function and even-
tually trigger apoptosis of the dopaminergic neurons. If recognized as evidence of massive and probably irrepa-
rable damage to cell constituents, leading to neurode-so, Hsps would be anticipated to play a role in retarding
the development of Parkinson’s Disease, either by re- generation and activation of the apoptotic program. Al-
though such a unifying mechanism remains unprovenducing a-synuclein aggregation, by promoting its solu-
bilization or degradation, or by inhibiting the events lead- and largely untested, these various observations em-
phasize that in very long-lived nondividing cells, suching to apoptosis.
as neurons, any rare event favoring production of an
aberrant protein (e.g., free radical damage) can lead toApoptosis and Inclusions in Other
its slow accumulation with toxic consequences. Be-Neurodegenerative Diseases
cause structural defects in any of a variety of neuronalAnother late-onset neurological disease that appears to
proteins can generate pathology, the proper functioninginvolve some similar cellular mechanisms is amyotro-
of the molecular chaperones and the ubiquitin-protea-phic lateral sclerosis (ALS), a rapidly progressive dis-
some pathway must be particularly important in hostease characterized by death of motor neurons (Brown,
defenses against neuronal degeneration.1998). Some of the hereditary forms of ALS are due to
mutations in superoxide dismutase, including ones that
cause a loss-of-function or a gain-of-function (Brown, Aging, Hsps, and Susceptibility
to Neurodegenerative Diseases1998; Cleveland, 1999). In transgenic animals express-
ing the mutant SODs, apoptosis is evident and can be An important common feature of these diseases that
has long puzzled investigators is their late onset. In mostretarded by central administration of caspase inhibitors
(Li et al., 2000) or by mutations affecting certain cas- cases, the marked neurodegeneration (e.g., in HD or
ALS) occurs in middle age or later (Brown, 1998; Young,pases (Friedlander and Yuan, 1998). Although seemingly
very different from other neurodegenerative diseases, 1998). The mechanisms proposed here for cell protec-
tion and pathology in these various conditions also sug-ALS in both its hereditary and acquired versions is asso-
ciated with the presence in affected motor neurons of gest a possible explanation for their late onset. The
onset of an inherited disease in middle age or later im-proteinaceous inclusions, that stain with antiubiquitin
antibodies (Mayer et al., 1996; Ii et al., 1997; Tu et al., plies that the affected neurons can deal successfully
with the mutant proteins for many years. During this1997; Kawashima et al., 1998; Shibata et al., 1999) and
contain excess neurofilaments. Development of these time, the potentially toxic polypeptides must be continu-
ally synthesized and degraded without causing diseaseinclusions containing the mutant form of SOD closely
resembles formation of aggresses (Johnston et al., symptoms or cell death, until with aging, abnormal mole-
cules accumulate in certain neurons and eventually2000). Although rigorous demonstration of abnormal
polypeptides is lacking in the common nonhereditary reach toxic levels. In other words, with aging, the cell’s
capacity to handle the aberrant polypeptides becomesform of ALS, there is evidence for oxidative or heavy
metal–mediated damage to neuronal proteins. Impor- insufficient to prevent their accumulation and toxic con-
sequences. It is noteworthy that earlier onset of diseasetantly, in culture the viability of neurons expressing the
mutant SOD can be protected by increasing their con- is seen in HD and related polyglutamine disease as the
extent of the abnormality in protein structure becomestent of Hsp70 (Bruening et al., 1999).
Alzheimer’s Disease, the most common cause of se- greater (i.e., as the length of the polyglutamine repeat
increases) (Young, 1998). Similarly, in transgenic mousenile dementia, appears (at least) superficially to be very
different from these other diseases. This condition is models of ALS, earlier onset occurs if the extent of
expression of the abnormal gene product is increasedassociated with extracellular amyloid plaques, but Alz-
heimer’s affected brains are also characterized by intra- (i.e., they show a gene dosage effect) (Cleveland, 1999).
We suggest that one important factor contributing tocellular accumulation of ubiquitin conjugated to the cy-
toskeletal protein tau, which also occurs in neurons in the enhanced sensitivity of aged organisms to these
disorders is a reduced capacity of cells from older indi-the much rarer disease progressive supranuclear palsy.
The molecular basis for these inclusions and their rela- viduals to cope with abnormal proteins. Of particular
interest in this regard are various observations indicat-tionship to the extracellular amyloid-related damage is
quite unclear. One intriguing observation is the finding ing that aged organisms and senescent cultures of
mammalian cells are less able to induce Hsps in re-in brains of some AD patients an anomalous form of
ubiquitin (van Leewen et al., 1998), resulting from tran- sponse to protein-damaging conditions (Rattan and Der-
ventzi, 1991; Heydari et al., 1994). For example, in ro-scriptional misreading of the stress-induced polyubiqui-
tin gene (see below). As a result, some ubiquitin mole- dents, the magnitude of the increase in Hsp expression
in various tissues, including brain, after a mild heatcules are generated with aberrant C-terminal extensions
and therefore can not be conjugated to substrates. Such shock is much smaller in aged animals than in young
ones (Heydari et al., 1994). A similar reduction with agingan extended version, however, can become linked to
other ubiquitin molecules and, in principle, such ubiqui- in the ability of rat and human tissues to induce Hsps
has been observed upon exposure to oxidative stresstin chains might competitively inhibit proteasomal func-
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and amino acid analogs (Locke and Tanguay, 1996; Mur- including oxidatively damaged polypeptides, ones con-
amatsu et al., 1996). taining isomerized residues and inactive proteins due
Since these Hsps can promote refolding, solubiliza- to altered conformations (Sastre et al., 1996; Chiu and
tion, and degradation of damaged polypeptides, the loss Liu, 1997; Mrak et al., 1997; Tarcsa et al., 2000). Also,
of this protective response should seriously compro- it was recently reported that brains of aged individuals
mise the cell’s capacity to cope with the mutant or dam- have a specific mechanism that causes frameshift muta-
aged proteins, which could have been handled success- tions at the RNA level and thus generation of nonsense
fully at younger ages. These considerations predict that polypeptides (van Leewen et al., 1998).
neurons from aged humans should be defective in in- With aging, cells also seem to have a reduced capacity
ducing Hsps when mutant huntingtin, ataxins, a-synu- for protein degradation. One proteolytic pathway clearly
clein, and other abnormal proteins tend to accumulate. affected by aging is the lysosomal pathway (Cuervo and
As a consequence of decreased Hsp inducibility, the Dice, 1998a), which catalyzes the breakdown of endocy-
mutant polypeptides should build up in cells of aged tosed components including most surface membrane
individuals to higher levels and result in a greater ten- proteins. The breakdown of proteins that are specifically
dency to form inclusions, to cause neurodegeneration, targeted to lysosomes for degradation is dramatically
and to trigger apoptosis. It is also interesting that cells reduced in senescent cultures and in cells isolated from
infected with the mutant prion protein (Tatzelt et al., aged organisms (Dice, 1993; Cuervo and Dice, 1998a).
1995) also show diminished capacity to induce Hsps, This defect seems to be due to a reduced capacity to
which may increase their vulnerability to prion-induced translocate polypeptides into lysosomes for degrada-
apoptosis. Furthermore, mutations in Presenilin 1, which tion (Hayes and Dice, 1996; Cuervo and Dice, 1996,
cause early onset of Alzheimer’s disease, reduce the 1998b). The capacity of the ubiquitin-proteasome path-
neuron’s capacity to induce chaperones in ER (Katay- way also seems to be reduced with aging, although
ama et al., 1999). This defect could contribute to the no systematic studies of this possibility in different cell
enhanced production of Ab peptide in these cells and types have been reported. In lenses from aged rats, the
to greater susceptibility of such cells to apoptosis and rate of ubiquitination of many proteins is much lower
neurodegeneration. than in young animals (Shang et al., 1997). Also, in aged
Because this loss of the ability to deal with abnormal mouse muscles, expression of mRNA for multiple com-
proteins upon aging may be the major factor determining ponents of this pathway is reduced (Shang et al., 1997).
the late onset of many neurodegenerative diseases, it Another potentially important age-related alteration is
seems of particular importance to pursue systematic the recently described mutant form of ubiquitin, re-
studies of the capacity of these mutant molecules to sulting from a frameshift at the RNA level (van Leewen
elicit the HS response at different ages and in different et al., 1998), which as noted above may indirectly reduce
parts of the brain. Information on the levels of these the cell’s capacity to degrade aberrant molecules. What-
proteins in human subjects with these neurodegenera- ever the basis for these intriguing observations, such
tive diseases (as well as on their levels in systemic dis- changes in the cell’s proteolytic capacity, and the gen-
eases resulting from mutated proteins) is presently lack- eral increase in unfolded molecules, should further limit
ing and is clearly important to obtain. In addition, human the capacity of the aged organism to cope with a mutant
variations or polymorphism affecting this protective re- protein or other abnormal polypeptides and may thus
sponse could account for differences in the penetrability indirectly contribute to the development of neurodegen-
of the hereditary forms of these diseases and in suscep- erative diseases.
tibility to the noninherited conditions. These questions
are particularly important to study since they also sug-
Conclusionsgest that a valuable new therapeutic approach to treat
In summary, a large body of knowledge has been gainedthese conditions or to delay their onset would be treat-
concerning the responses of prokaryotic and eukaryoticments that induce the Hsps. It is noteworthy that senes-
cells that protect against an accumulation of mutant orcent cultures seem to lose the ability to induce Hsps in
damaged proteins, and these insights should have aresponse to certain stimuli, but not to all (Volloch et
major impact on our thinking about neurodegenerativeal., 1998). For these reasons, it will be of appreciable
diseases. In all cells, including neurons, unfolded pro-importance to determine the biochemical basis for the
teins activate the expression of Hsps, which enhanceloss of inducibility of these proteins with aging.
the cell’s capacity (1) to prevent protein aggregation, (2)Decreased expression or inducibility of chaperones
to disassociate such aggregates once formed, (3) toand components of the degradative system may also
refold denatured molecules, (4) to isolate such polypep-account for the large number of observations suggesting
tides in inclusions (“aggresomes”), and (5) to degradethe presence in aged organisms and senescent cultures
selectively the abnormal polypeptides. In addition, (6)of various types of abnormal polypeptides (Sastre et al.,
if these protective mechanisms are overwhelmed, the1996; Grune et al., 1997). The early proposal that aging
abnormal molecules can trigger activation of stress-was due to increased errors in gene transcription or
kinase JNK and apoptosis, but even this cell death pro-translation leading to an “error catastrophe” (i.e., death)
gram can be blocked if the levels of certain Hsps arehas not been supported (Orgel, 1963). Though mathe-
increased. It is therefore of particular importance to de-matically elegant, this theory was naive in ignoring the
termine to what extent these fundamental cellular mech-continual turnover of cell proteins and the cell’s selective
anisms are functioning during the development and thecapacity to selectively degrade abnormal proteins. Nev-
progression of these various neurodegenerative dis-ertheless, there is abundant evidence for an increased
content of abnormal proteins in cells of aged organisms, eases. It is noteworthy and probably not accidental that
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protein 70 inhibits apoptosis by preventing recruitment of procas-all three known human diseases due to mutations in
pase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2, 469–475.ubquitination enzymes are associated with neurodegen-
Benaroudj, N., and Goldberg, A.L. (2000). PAN, the proteasome-eration. Since aging is associated with a general de-
activating nucleotidase from archaebacteria, is a protein-unfoldingcrease in the inducibility of Hsps and with a buildup of
molecular chaperone. Nat. Cell Biol. 2, 833–839.
various types of protein abnormalities, it seems likely
Bennett, M.C., Bishop, J.F., Leng, Y., Chock, P.B., Chase, T.N., andthat the late onset of these conditions results in part
Mouradian, M.M. (1999). Degradation of alpha-synuclein by protea-
from the loss of these protective mechanisms in aged some. J. Biol. Chem. 274, 33855–33858.
individuals, leading eventually to the abnormal species Bercovich, B., Stancovski, I., Mayer, A., Blumenfeld, N., Laszlo, A.,
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learned about the inducibility and functioning of specific degradation of certain protein substrates in vitro requires the molec-
ular chaperone Hsc70. J. Biol. Chem. 272, 9002–9010.chaperones and the ubiquitin-proteasome pathway in
Beris, P., Miescher, P.A., Diaz-Chico, J.C., Han, I.S., Kutlar, A., Hu,neurons with aging. Such studies appear very important
H., Wilson, J.B., and Huisman, T.H. (1988). Inclusion body beta-to undertake, since genetic polymorphism in these pro-
thalassemia trait in a Swiss family is caused by an abnormal hemo-tective systems and in their expression with aging
globin (Geneva) with an altered and extended beta chain carboxy-
may play critical roles in the accumulation of abnormal terminus due to a modification in codon beta 114. Blood 72, 801–805.
proteins and the pathogenesis of disease. Moreover,
Braun, B.C., Glickman, M., Kraft, R., Dahlmann, B., Kloetzel, P.M.,
pharmacological induction or activation of these protein Finley, D., and Schmidt, M. (1999). The base of the proteasome
repair and degradative systems could represent an at- regulatory particle exhibits chaperone-like activity. Nat. Cell Biol. 1,
221–226.tractive new approach to treatment or delaying the neu-
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